Cargando…
Ramadan fasting: recommendations for patients with cardiovascular disease
Ramadan fasting is observed by most of the 1.8 billion Muslims around the world. It lasts for 1 month per the lunar calendar year and is the abstention from any food and drink from dawn to sunset. While recommendations on ‘safe’ fasting exist for patients with some chronic conditions, such as diabet...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819657/ https://www.ncbi.nlm.nih.gov/pubmed/33990414 http://dx.doi.org/10.1136/heartjnl-2021-319273 |
_version_ | 1784646097264705536 |
---|---|
author | Akhtar, Abid Mohammed Ghouri, Nazim Chahal, C. Anwar A Patel, Riyaz Ricci, Fabrizio Sattar, Naveed Waqar, Salman Khanji, Mohammed Yunus |
author_facet | Akhtar, Abid Mohammed Ghouri, Nazim Chahal, C. Anwar A Patel, Riyaz Ricci, Fabrizio Sattar, Naveed Waqar, Salman Khanji, Mohammed Yunus |
author_sort | Akhtar, Abid Mohammed |
collection | PubMed |
description | Ramadan fasting is observed by most of the 1.8 billion Muslims around the world. It lasts for 1 month per the lunar calendar year and is the abstention from any food and drink from dawn to sunset. While recommendations on ‘safe’ fasting exist for patients with some chronic conditions, such as diabetes mellitus, guidance for patients with cardiovascular disease is lacking. We reviewed the literature to help healthcare professionals educate, discuss and manage patients with cardiovascular conditions, who are considering fasting. Studies on the safety of Ramadan fasting in patients with cardiac disease are sparse, observational, of small sample size and have short follow-up. Using expert consensus and a recognised framework, we risk stratified patients into ‘low or moderate risk’, for example, stable angina or non-severe heart failure; ‘high risk’, for example, poorly controlled arrhythmias or recent myocardial infarction; and ‘very high risk’, for example, advanced heart failure. The ‘low-moderate risk’ group may fast, provided their medications and clinical conditions allow. The ‘high’ or ‘very high risk’ groups should not fast and may consider safe alternatives such as non-consecutive fasts or fasting shorter days, for example, during winter. All patients who are fasting should be educated before Ramadan on their risk and management (including the risk of dehydration, fluid overload and terminating the fast if they become unwell) and reviewed after Ramadan to reassess their risk status and condition. Further studies to clarify the benefits and risks of fasting on the cardiovascular system in patients with different cardiovascular conditions should help refine these recommendations. |
format | Online Article Text |
id | pubmed-8819657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-88196572022-02-16 Ramadan fasting: recommendations for patients with cardiovascular disease Akhtar, Abid Mohammed Ghouri, Nazim Chahal, C. Anwar A Patel, Riyaz Ricci, Fabrizio Sattar, Naveed Waqar, Salman Khanji, Mohammed Yunus Heart Review Ramadan fasting is observed by most of the 1.8 billion Muslims around the world. It lasts for 1 month per the lunar calendar year and is the abstention from any food and drink from dawn to sunset. While recommendations on ‘safe’ fasting exist for patients with some chronic conditions, such as diabetes mellitus, guidance for patients with cardiovascular disease is lacking. We reviewed the literature to help healthcare professionals educate, discuss and manage patients with cardiovascular conditions, who are considering fasting. Studies on the safety of Ramadan fasting in patients with cardiac disease are sparse, observational, of small sample size and have short follow-up. Using expert consensus and a recognised framework, we risk stratified patients into ‘low or moderate risk’, for example, stable angina or non-severe heart failure; ‘high risk’, for example, poorly controlled arrhythmias or recent myocardial infarction; and ‘very high risk’, for example, advanced heart failure. The ‘low-moderate risk’ group may fast, provided their medications and clinical conditions allow. The ‘high’ or ‘very high risk’ groups should not fast and may consider safe alternatives such as non-consecutive fasts or fasting shorter days, for example, during winter. All patients who are fasting should be educated before Ramadan on their risk and management (including the risk of dehydration, fluid overload and terminating the fast if they become unwell) and reviewed after Ramadan to reassess their risk status and condition. Further studies to clarify the benefits and risks of fasting on the cardiovascular system in patients with different cardiovascular conditions should help refine these recommendations. BMJ Publishing Group 2022-02 2021-05-14 /pmc/articles/PMC8819657/ /pubmed/33990414 http://dx.doi.org/10.1136/heartjnl-2021-319273 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Akhtar, Abid Mohammed Ghouri, Nazim Chahal, C. Anwar A Patel, Riyaz Ricci, Fabrizio Sattar, Naveed Waqar, Salman Khanji, Mohammed Yunus Ramadan fasting: recommendations for patients with cardiovascular disease |
title | Ramadan fasting: recommendations for patients with cardiovascular disease |
title_full | Ramadan fasting: recommendations for patients with cardiovascular disease |
title_fullStr | Ramadan fasting: recommendations for patients with cardiovascular disease |
title_full_unstemmed | Ramadan fasting: recommendations for patients with cardiovascular disease |
title_short | Ramadan fasting: recommendations for patients with cardiovascular disease |
title_sort | ramadan fasting: recommendations for patients with cardiovascular disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819657/ https://www.ncbi.nlm.nih.gov/pubmed/33990414 http://dx.doi.org/10.1136/heartjnl-2021-319273 |
work_keys_str_mv | AT akhtarabidmohammed ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT ghourinazim ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT chahalcanwara ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT patelriyaz ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT riccifabrizio ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT sattarnaveed ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT waqarsalman ramadanfastingrecommendationsforpatientswithcardiovasculardisease AT khanjimohammedyunus ramadanfastingrecommendationsforpatientswithcardiovasculardisease |